Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke

Reuters - 02-21

0LASgEoE

(Reuters) - Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.